Citi downgrades Somanetics Corp (Nasdaq: SMTS) from Buy to Hold.

Citi analyst says, "After a significant ~35% rise in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE